Could islet cell shots free type 1 diabetics from insulin?
NCT ID NCT06731218
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 24 times
Summary
This early-stage trial tests a new treatment called RGB-5088 for people with type 1 diabetes. It involves injecting special islet cells that can produce insulin, aiming to help the body control blood sugar better and prevent dangerous low blood sugar events. The study will include 10 adults aged 18-60 who have had severe hypoglycemia in the past year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin First Center Hospital
RECRUITINGTianjin, Tianjin Municipality, 300000, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.